Abstract
To detect a ±40% difference in area under the curve (AUC) of progestin norethindrone (NET) 0–72 h following oral administration of 0.35 mg of NET in HIV-positive women taking protease inhibitors (PI), compared with AUC of NET in HIV-positive women taking another antiretroviral (ARV) regimen that has shown no significant change in oral NET levels in prior trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.